CUE SCHEDULE 13G/A: SEC filing
Bleichroeder LP
Filed with the SEC on · accession 0001420506-26-002561
CUE filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 10, 2026. Bleichroeder LP filed an amended Schedule 13G reporting beneficial ownership of 663,009 shares (8.77%) of Cue Biopharma common stock, including 296,857 shares issuable upon exercise of warrants. The stock moved -6.9% by the first close after the filing.
Summary of the filing
Bleichroeder LP filed an amended Schedule 13G reporting beneficial ownership of 663,009 shares (8.77%) of Cue Biopharma common stock, including 296,857 shares issuable upon exercise of warrants. The filing is a passive investment disclosure with no intent to influence control of the company.
Key details
How CUE stock reacted
Close before
$20.14
Nov 9, 2026
First close after
-6.85%
$18.76
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for CUE, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CUE?
Click hereFrequently asked questions
What did CUE file with the SEC on Nov 10, 2026?
CUE filed a SCHEDULE 13G/A (SEC filing). Bleichroeder LP filed an amended Schedule 13G reporting beneficial ownership of 663,009 shares (8.77%) of Cue Biopharma common stock, including 296,857 shares issuable upon exercise of warrants. The filing is a passive investment disclosure with no intent to influence control of the company.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did CUE stock react to this filing?
CUE closed at $20.14 before the filing and $18.76 on Nov 10, 2026 (-6.85%).
Other CUE SEC filings
Get alerts when CUE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days